Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

188Rhenium-hydroxyethylidene-1,1-diphosphonate (188Re-HEDP) is a clinically established radiopharmaceutical for bone pain palliation of patients with metastatic bone cancer. Herein, the effectiveness of 188Re-HEDP for the palliation of painful bone metastases was investigated in an uncontrolled init...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajit Shinto, Madhava Mallia, Mythili Kameswaran, K Kamaleshwaran, Jephy Joseph, E Radhakrishnan, Indira Upadhyay, R Subramaniam, Madhu Sairam, Sharmila Banerjee, Ashutosh Dash
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-10-01
Series:World Journal of Nuclear Medicine
Subjects:
bone metastasis
hydroxyethylidene-1
1-diphosphonate
pain palliation
radionuclide therapy
rhenium-188
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_68_17
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items